CIK 0001873835
- Emerging growth company
Immix Biopharma, Inc.
Sign in to watch- Ticker
- IMMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454869378
- Phone
- +1 888-958-1084
- Business address
- 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
- Former names
- Immix Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-22 | Marquet Magda Director | Grant or award | +6,250 | 52,342 | ||
| 2026-05-22 | Marquet Magda Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2025-06-20 | Marquet Magda Director | Grant or award · Stock Option (Right to Buy) | +33,000 | 33,000 | ||
| 2024-06-11 | Marquet Magda Director | Grant or award · Stock Option (Right to Buy) | +33,000 | 33,000 | ||
| 2024-05-20 | Marquet Magda Director | Grant or award | +21,155 | 46,092 | ||
| 2024-05-15 | Marquet Magda Director | Grant or award | +25,002 | 25,002 | ||
| 2023-09-06 | Marquet Magda Director | Purchase | +9,000 | $2.47 | $22K | 20,000 |
| 2023-09-05 | Marquet Magda Director | Purchase | +10,000 | $2.47 | $25K | 11,000 |
| 2023-08-31 | Marquet Magda Director | Purchase | +1,000 | $2.01 | $2K | 1,000 |
| 2023-08-11 | Marquet Magda Director | Grant or award · Stock Options | +20,000 | 20,000 | ||
| 2022-07-14 | Marquet Magda Director | Grant or award · Stock Options | +16,000 | 76,000 |
Page 1 of 1 · 11 trades